-
Update on Emerging HIV Drug Resistance to Integrase Inhibitors...
08 Apr 2024 11:53 GMT
… Health Organization recommended using the integrase inhibitor, dolutegravir (DTG), in first- and … drug resistance to HIV-1 integrase inhibitors, with a focus on dolutegravir … the impact of resistance to integrase inhibitors on both public health and …
-
Switching to integrase inhibitor may accelerate weight gain during menopause inHIV patients: Study
26 Mar 2024 21:42 GMT
Integrase strand transfer inhibitors (INSTIs) are associated with more significant weight gain in women with HIV (WWH) compared to men with HIV. Menopausal transition leads to changes in body composition.
A finding published in CROI, Conference on …
-
Switch to an integrase inhibitor leads to greater weight during and after the menopause
11 Mar 2024 13:23 GMT
… before switching to an integrase inhibitor
Switching to an integrase inhibitor around the time … appear to suppress weight gain. Integrase inhibitors on the other hand, especially … , a switch to an integrase inhibitor was associated with significantly faster …
-
HIV Drugs Market To Surpass USD 43.06 Billion By 2031, Fueled With Expanding Treatment Programs
16 Apr 2024 17:07 GMT
… Drugs Market
By Drug Class
→Integrase Inhibitors
→Non- Nucleoside Reverse Transcriptase inhibitors …
-
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care
16 Apr 2024 07:27 GMT
… al. Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a large cohort …
-
More evidence that integrase inhibitors don’t raise heart disease risk
10 Nov 2023 09:46 GMT
… regimens. People starting integrase inhibitors had significantly higher baseline … of integrase inhibitor recipients and 6% of non-integrase inhibitor recipients … integrase inhibitor-containing regimens – thereby taking account of the drugs integrase inhibitors …
-
News24 | Widely used HIV drug in SA flagged for reports of resistance - but experts say don't panic
15 Apr 2024 11:06 GMT
… have been exposed to other integrase inhibitors [a class of antiretroviral drug … Wits University. (Besides dolutegravir, other integrase inhibitors include raltegravir, bictegravir, and cabotegravir …
-
Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs)
13 Oct 2023 11:30 GMT
… adiposity that commonly occur with integrase inhibitors.” Tesamorelin, a growth hormone- … with HIV who are on integrase inhibitors, potential treatment strategies will … people with HIV treated with integrase inhibitor based regimens. Forward-Looking …
-
FDA Approves Dovato for Teens Living With HIV
15 Apr 2024 13:47 GMT
… news release.
Dovato combines the integrase inhibitor dolutegravir (sold separately as Tivicay …
-
Do Integrase Inhibitors Raise the Risk for Cardiovascular Disease?
19 Sep 2023 21:26 GMT
… about the link between integrase inhibitors—especially dolutegravir—and metabolic … and several studies have implicated integrase inhibitors specifically. Excess weight—especially … , but not for other integrase inhibitors (for example, bictegravir or …